The Role Of Local Anesthetics in the Management of Adverse Effects Associated With Intrauterine Device Application
- Conditions
- IUDContraceptionPain
- Interventions
- Other: with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) )
- Registration Number
- NCT04379102
- Brief Summary
Patients who visited our family planning clinic and opted for IUD application for contraception purposes were also offered NT/TLA treatments simultaneously. 40 patients who matched the inclusion criteria and received IUDs and NT/TLA treatments were included in the study group and 41 patients who only received IUDs were included in the control group. All patients received copper IUDs and none of them were on additional hormonal treatment. Before the insertion of IUD, women in the therapy group received NT treatment with 6ml of 1% procaine injected transvaginal into the cervix at 5 and 7 o'clock localizations. Following IUD insertion, another 6ml of 1% procaine was injected into the Frankenhauser ganglia bilaterally. A final dose of 8ml of 1% procaine was injected into the abdominal trigger points and intracutaneously into the L4-S4 dermatomes as quaddles.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 80
- not pregnant women
- healty women age between 18- 45 years old
- chronic diseases which could cause chronic pelvic pain such as endometriosis
- which makes them prone to infections such as diabetes mellitus
- complication had arised during the IUD insertion, such as uterine perforation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description IUD patients with NT/TLA (NT or also referred to as therapy with local anesthetics (TLA) ) 80 patients who matched the inclusion criteria and received IUDs
- Primary Outcome Measures
Name Time Method The VAS scores of patients after the application of IUDs 1 month The VAS scores of patients in both groups reported one month after the application of IUDs (Patients mark their pain intensity from 1 to 10 in vas scoring. In scoring, 1 point is the lowest score and shows that the patient has low pain, 10 is the highest score and shows severe pain.)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Pinar Yalcin Bahat
🇹🇷Istanbul, İ̇stanbul, Turkey